Literature DB >> 1159438

Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

R Sjöström, J Ekstedt, E Anggård.   

Abstract

The monamine metabolites 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), vanillylmandelic acid (VMA), and 4-hydroxy-3-methoxyphenylglycol (HMPG) were analysed in CSF from different regions of the CSF system to study the caudocranial concentration gradient of the metabolites. Four consecutive 10 ml fractions of CSF were withdrawn in 17 patients during the course of four minutes. The CSF pressure was monitored through a lumbar cannula because of suspected adult hydrocephalus. A pronounced gradient of the HVA concentration was found with a ratio between the last and the first fraction of 1,7. 5-HIAA showed a slight increase while HMPG and VMA showed no increase at higher levels of the CSF system. The results suggest that lumbar HVA reflects dopaminergic activity in the brain, whereas lumbar 5-HIAA and HMPG/VMA reflect the activity of 5-hydroxytryptamine and noradrenaline secreting neurones in both the brain and the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159438      PMCID: PMC1083245          DOI: 10.1136/jnnp.38.7.666

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Casts of the cerebral ventricles.

Authors:  R J LAST; D H TOMPSETT
Journal:  Br J Surg       Date:  1953-05       Impact factor: 6.939

2.  Mass fragmentographic determination of 4-hydroxy-3-methoxymandelic acid in human urine, cerebrospinal fluid, brain and serum using a deuterium-labelled internal standard.

Authors:  B Sjöquist
Journal:  J Neurochem       Date:  1975-01       Impact factor: 5.372

3.  Cholinergic and dopaminergic mechanisms in Huntington's chorea.

Authors:  S M Aquilonius; R Sjöström
Journal:  Life Sci I       Date:  1971-04-01

Review 4.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

Authors:  A T Moir; G W Ashcroft; T B Crawford; D Eccleston; H C Guldberg
Journal:  Brain       Date:  1970       Impact factor: 13.501

5.  5-hydroxyindoleacetic cid in spinal fluid: relative contribution from brain and spinal cord.

Authors:  R L Weir; T N Chase; L K Ng; I J Kopin
Journal:  Brain Res       Date:  1973-03-30       Impact factor: 3.252

6.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

Authors:  R Sjöström; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

7.  Mass fragmentographic determination of homovanillic acid in tissues and body fluids using the deuterium labeled species as internal standard.

Authors:  B Sjöquist; B Lindström; E Anggård
Journal:  Life Sci       Date:  1973-12-16       Impact factor: 5.037

8.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

9.  Mass fragmentographic determination of 4-hydroxy-3-methoxyphenylglycol (HMPG) in urine, cerebrospinal fluid, plasma and tissues using a deuterium-labelled internal standard.

Authors:  B Sjöquist; B Lindström; E Anggård
Journal:  J Chromatogr       Date:  1975-02-26

10.  Origin of 5-hydroxyindoleacetic acid in the spinl fluid.

Authors:  M Bulat; B Zivković
Journal:  Science       Date:  1971-08-20       Impact factor: 47.728

View more
  21 in total

Review 1.  Measuring the activity of brain adrenergic receptors in man.

Authors:  S al-Damluji
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

2.  N-Acetyl-aspartylglutamate (NAAG) in human cerebrospinal fluid: Determination by high performance liquid chromatography, and influence of biological variables.

Authors:  V Brovia; A Ricciardi; L Barbeito
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

3.  Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus.

Authors:  K Kmieciak-Kolada; H Majchrzak; Z S Herman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-01       Impact factor: 10.154

4.  Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders.

Authors:  R P Iacono; S M Kuniyoshi; J R Ahlman; G J Zimmerman; G Maeda; R D Pearlstein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.

Authors:  R J Polinsky; R T Brown; R S Burns; J Harvey-White; I J Kopin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

6.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluid.

Authors:  G D Prell; J K Khandelwal; P A LeWitt; J P Green
Journal:  Agents Actions       Date:  1989-03

8.  Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.

Authors:  P Ashby; M Verrier; J J Warsh; K S Price
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

9.  Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography.

Authors:  A Spissu; S Congia; M P Piccardi; F Fadda; A Mangoni; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.

Authors:  H von Holst; C Lindquist; G Sedvall
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.